Introduction
Increasingly, abnormal metabolic substrate utilisation is considered a cause of heart failure (HF). Hyperpolarised 13 C MR, a technique in which the fate of 13 C-labelled metabolites can be followed in vivo using MR imaging or spectroscopy, has enabled non-invasive assessment of cardiac substrate utilisation.
Purpose
The aim of this study was to monitor carbohydrate metabolism alongside cardiac structure and function, throughout HF progression.
Methods
Dilated cardiomyopathy (DCM) was induced in pigs (n = 4) by rapid ventricular pacing at 188 bpm for 4-5 weeks. Pigs were examined at baseline and at weekly time points throughout DCM progression. At each time point, cine MRI was used to assess cardiac structure and function, 0.05 mmol/kg hyperpolarised 13 C 2 -pyruvate was administered intravenously and MRS was used to assess Krebs cycle-mediated 13 C-glutamate production, and hyperpolarised C images of the healthy pig heart, acquired with a surface coil. B) Comparison of parameters of structural and metabolic remodeling in the pig heart throughout the progression of DCM. *p<0.05.
respiratory-gated 13 C MRI sequence was used to image 13 C 1 -pyruvate and H 13 CO 3 -. The chemical shift-specific pulse sequence used allowed temporally resolved imaging of 13 C 1 -pyruvate and H 13 CO 3 -with 9 mm in-plane spatial resolution in multiple slices (two in these studies), all within a 23 s scan. Pigs were sacrificed after presentation of clinical symptoms or >25% increase in end diastolic volume (EDV).
Results
At baseline, pigs had an EDV of 62 ± 5 ml. The maximum 13 C-glutamate/ 13 C 2 -pyruvate ratio was 4.9 ± 1.2% (Fig 1A) , whereas the mean H 13 CO 3 -/ 13 C 1 -pyruvate ratio across the anterior myocardium was 2.0 ± 0.3% (Fig 1B) . After 1 week of pacing, the 13 C-glutamate/ 13 C 2 -pyruvate decreased significantly to 2.1 ± 0.8%, and was maintained at this level throughout DCM development. EDV increased linearly with pacing duration, and after 2-3 weeks of pacing was significantly elevated to 84 ± 12 ml. After 4-5 weeks of pacing (at the final time point), the ejection fraction (EF) was decreased by 40% compared with the baseline value, and the H 13 CO 3 -/ 13 C 1 -pyruvate was decreased to 0.8±0.2%.
Conclusions
In conclusion, metabolism of 13 C 2 -pyruvate to 13 Cglutamate was reduced by 59% at an early stage in DCM, with no change to PDH flux. Reduced 13 C-glutamate relative to H 13 CO 3 -production could be an early marker of disease. Carbohydrate oxidation via PDH was maintained until end-stage DCM, at which point PDH flux was reduced by 62%. With further development, metabolic imaging using hyperpolarised 13 C MR may similarly characterize HF progression in patients. 
